Related Experiment Video
Updated: May 21, 2026
08:18
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
Published on: July 27, 2022
Fish oil supplementation & coronary artery disease: does it help?
1Division of Cardiovascular Medicine, University of Missouri School of Medicine, USA. webelr@health.missouri.edu
Missouri Medicine
|June 9, 2012
Summary
Omega-3 fatty acids can lower the risk of cardiovascular disease, including heart attacks and strokes. This review explores their benefits for treating coronary artery disease (CAD) with minimal side effects.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
Background:
- Cardiovascular disease (CVD) remains a leading cause of mortality worldwide.
- Omega-3 polyunsaturated fatty acids (PUFAs) are recognized for their cardioprotective effects.
- Coronary artery disease (CAD) is a major manifestation of CVD.
Purpose of the Study:
- To review the existing scientific literature on Omega-3 PUFAs for CAD treatment.
- To discuss the potential benefits and therapeutic role of Omega-3 fatty acids in managing CAD.
Main Methods:
- Literature review of studies investigating Omega-3 PUFAs and cardiovascular outcomes.
- Analysis of data on the impact of Omega-3s on myocardial infarction, stroke, and mortality.
- Assessment of tolerability and adverse effects associated with Omega-3 supplementation.
Main Results:
- Omega-3 PUFAs demonstrate a significant reduction in fatal and non-fatal myocardial infarction.
- Evidence suggests a decreased risk of stroke and sudden cardiac death with Omega-3 intake.
- Studies indicate a reduction in all-cause mortality among individuals supplemented with Omega-3 fatty acids.
Conclusions:
- Omega-3 PUFAs are well-tolerated and offer a favorable safety profile.
- The evidence supports the use of Omega-3 fatty acids as a beneficial intervention for coronary artery disease.
- Further research can elucidate optimal dosages and specific mechanisms for CAD management.
Related Concept Videos
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...